An Early Cost-Utility Model of mRNA-Based Therapies for the Treatment of Methylmalonic and Propionic Acidemia in the United Kingdom Pablo E. Bretos-AzconaMatthew WallaceAgota Szende Original Research Article 25 May 2024
Systematic Review with Meta-analysis: Efficacy and Safety of Upadacitinib in Managing Moderate-to-Severe Crohn’s Disease and Ulcerative Colitis Chengu NiuJing ZhangPatrick I. Okolo 3rd Systematic Review 23 May 2024
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Oral AL01211 in Healthy Chinese Volunteers Lei DongJianxing XiangJianhong Zheng Original Research Article 02 May 2024
Prediction Model for Severe Thrombocytopenia Induced by Gemcitabine Plus Cisplatin Combination Therapy in Patients with Urothelial Cancer Noriaki MatsumotoTomohiro MizunoShigeki Yamada Original Research Article 29 April 2024 Pages: 357 - 366
Differential Utility Losses in Herpes Zoster Cases Between Vaccinated and Unvaccinated Subjects: A Meta-analysis of Three Clinical Trials Nikolaos GiannelosBernard FrancqDesmond Curran Original Research Article Open access 25 April 2024 Pages: 293 - 301
Safety, Tolerability, and Pharmacokinetics of Oral BI 1358894 in Healthy Japanese Male Volunteers Jangsoo YoonVikas SharmaAkiko Harada Original Research Article Open access 24 April 2024 Pages: 319 - 328
Risk of Cardiovascular Events in Schizophrenic Patients Treated with Paliperidone Palmitate Once-Monthly Injection (PP1M): A Population-Based Retrospective Cohort Study in Taiwan Shih-Pei ShenLi YanChao-Hsiun Tang Original Research Article Open access 15 April 2024 Pages: 329 - 341
Pharmacokinetic Interactions Between Tegoprazan and the Combination of Clarithromycin, Amoxicillin and Bismuth in Healthy Chinese Subjects: An Open-Label, Single-Center, Multiple-Dosage, Self-Controlled, Phase I Trial Yujing DuLixiu YuYongning Lu Original Research Article 13 April 2024 Pages: 343 - 355
Impact of Viloxazine Extended-Release Capsules (Qelbree®) on Select Cytochrome P450 Enzyme Activity and Evaluation of CYP2D6 Genetic Polymorphisms on Viloxazine Pharmacokinetics Zhao WangTesfaye LiransoAzmi Nasser Original Research Article Open access 10 April 2024 Pages: 303 - 317
Real-World Effectiveness of Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists (OW GLP-1RAs) in Comparison with Dipeptidyl Peptidase-4 Inhibitors (DPP-4is) for Glycemic Control and Weight Outcomes in Type 2 Diabetes Mellitus (RELATE) Xi TanVictoria DivinoAaron A. King Original Research Article Open access 20 March 2024 Pages: 271 - 284
Experience of Tofacitinib Use in Pregnancy in Patients with Ulcerative Colitis María ChaparroDaniel CeballosJavier P. Gisbert Research Letter Open access 19 March 2024 Pages: 285 - 288
Should Glucokinase be Given a Chance in Diabetes Therapeutics? A Clinical-Pharmacological Review of Dorzagliatin and Lessons Learned So Far Upinder KaurBhairav Kumar PathakSankha Shubhra Chakrabarti Review Article 09 March 2024 Pages: 223 - 250
Effectiveness of Dose Increase in Upadacitinib from 15 mg to 30 mg for Patients with Moderate-to-Severe Atopic Dermatitis: A Real-World Clinical Practice in Japan Teppei HaginoRisa HamadaNaoko Kanda Original Research Article 06 March 2024 Pages: 261 - 269
Tolvaptan Treatment and Long-Term Impact on Quality of Life in Autosomal Dominant Polycystic Kidney Disease Patients: A Pilot Study Gianni CarraroValentina Di VicoLorenzo A. Calò Research Letter 02 March 2024 Pages: 289 - 291
An Open-Label Study to Assess Monthly Risperidone Injections (180 mg) Following Switch from Daily Oral Risperidone (6 mg) in Stable Schizophrenic Patients David P. WallingSunita N. ShindeCeline M. Laffont Original Research Article Open access 22 February 2024 Pages: 251 - 260
Cost-Effectiveness Evaluation of Oral CGRP Antagonists, Atogepant and Rimegepant, for the Preventative Treatment of Episodic Migraine: Results from a US Societal Perspective Model Ryan ThaliffdeenAnthony YuKaren Rascati Original Research Article 21 February 2024 Pages: 209 - 217
Thromboembolic Events Associated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Pharmacovigilance Analysis of the US FDA Adverse Event Reporting System (FAERS) Database Xiongwen YangBo YangChengxiao Fu Original Research Article 20 February 2024 Pages: 199 - 207
Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19: Evidence from the US National COVID Cohort Collaborative (N3C) Christopher F. BellPriyanka Bobbilithe N3C consortium Original Research Article Open access 20 February 2024 Pages: 183 - 198
Safety and Efficacy of Biologic Medications and Janus Kinase Inhibitors in Patients with Down Syndrome: A Retrospective Cohort Study Linnea WesterkamLauren PearsonChristopher Sayed Research Letter 19 February 2024 Pages: 219 - 222
Safety of Intravenous Push Valproate Compared with Intravenous Piggyback at a Tertiary Academic Medical Center Felicia Y. WangKevin C. McLaughlinRobert E. Dannemiller Original Research Article 16 February 2024 Pages: 175 - 181
Effect of Ticagrelor versus Clopidogrel on All-Cause and Cardiovascular Mortality in Acute Coronary Syndrome Patients with Hyperuricemia Shanshan NieYuhang ZhaoGuoping Yang Original Research Article 07 February 2024 Pages: 163 - 174
Cost-Effectiveness Analysis of Camrelizumab Plus Rivoceranib Versus Sorafenib as a First-Line Therapy for Unresectable Hepatocellular Carcinoma in the Chinese Health Care System Wenwang LangLian DengMing Ouyang Original Research Article 01 February 2024 Pages: 149 - 162
Forty-Eight-Month Monitoring of Disease Activity in Patients with Long-Standing Rheumatoid Arthritis Treated with TNF-α Inhibitors: Time for Clinical Outcome Prediction and Biosimilar vs Biologic Originator Performance Matteo ColinaMicheline KhodeirGabriele Campana Original Research Article Open access 31 January 2024 Pages: 141 - 148
Correction to: Association Between Antidiabetic Drugs and Delirium: A Study Based on the Adverse Drug Event Reporting Database in Japan Yukiko IshibashiRintaro SogawaChisato Shimanoe Correction 10 January 2024 Pages: 121 - 121
Demystifying Dry Powder Inhaler Resistance with Relevance to Optimal Patient Care Toby G. D. CapstickSanjay GudimetlaOmar S. Usmani Practical Application Open access 10 January 2024 Pages: 109 - 114
A Real-World Observational Study to Evaluate the Safety and Effectiveness of Fluticasone Furoate–Oxymetazoline Fixed Dose Combination Nasal Spray in Patients with Allergic Rhinitis Meenesh R. JuvekarGauri Kapre VaidyaRavi T. Mehta Original Research Article 09 January 2024 Pages: 123 - 130
Maximizing the Value of Chronic Myeloid Leukemia Management Using Tyrosine Kinase Inhibitors in the USA: Potential Determinants and Consequences of Healthcare Resource Utilization and Costs, with Proposed Optimization Approaches Jeffrey H. Lipton Systematic Review 05 January 2024 Pages: 91 - 108
Antibiotic-Associated Acute Kidney Injury Among Older Adults: A Case-Crossover Study Tichawona ChinzowuTe-yuan ChyouPrasad S. Nishtala Original Research Article 03 January 2024 Pages: 131 - 139
Association Between Antidiabetic Drugs and Delirium: A Study Based on the Adverse Drug Event Reporting Database in Japan Yukiko IshibashiRintaro SogawaChisato Shimanoe Original Research Article 23 December 2023 Pages: 115 - 120
Real-World Effectiveness and Safety of Baricitinib in Patients with Atopic Dermatitis Egídio FreitasMaria João Paiva LopesTiago Torres Research Letter 19 December 2023 Pages: 87 - 90
Food Effect on the Pharmacokinetics of VC004, a Tropomyosin Receptor Kinase Inhibitor: A Randomized Crossover Trial in Healthy Chinese Subjects Linlin HuQiuyue SunYongqiang Liu Original Research Article 19 December 2023 Pages: 79 - 85
Comparison of Long-Term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis Between Dupilumab-Exposed and Dupilumab-Naïve Patients Maddalena NapolitanoSilvia Mariel FerrucciCataldo Patruno Original Research Article 17 December 2023 Pages: 71 - 77
Cost Effectiveness of Tofacitinib for the Treatment of Active Ankylosing Spondylitis in Greece George GourzoulidisArgyro SolakidiCharalampos Tzanetakos Original Research Article 16 December 2023 Pages: 59 - 69
Lecanemab: More Questions Than Answers! Upinder KaurJaideep ReddySankha Shubhra Chakrabarti Current Opinion 14 December 2023 Pages: 1 - 10
Needle-Free Jet Injector-Assisted Triamcinolone Treatment of Keloids and Hypertrophic Scars is Effective and Well Tolerated in Children Vazula Zulfra BekkersClaire Van EijsdenMartijn Bastiaan Adriaan van Doorn Original Research Article 13 December 2023 Pages: 51 - 57
Comparison of the Incidence of Adverse Events Between Japanese and Non-Japanese Healthy Subjects in Phase I Studies: A Systematic Review and Meta-Analysis Satomi SakuraiKazuhiro MatsuiMamoru Narukawa Systematic Review 02 December 2023 Pages: 11 - 19
Key Drivers of Coagulation Factor Use in Von Willebrand Disease During Hospitalization: An Overview of the French BERHLINGO Cohort Valérie HorvaisPhilippe Beurrierthe BERHLINGO Consortium Original Research Article 30 November 2023 Pages: 35 - 49
Characterization of the Pharmacokinetics and Mass Balance of a Single Oral Dose of Trofinetide in Healthy Male Subjects Mona DarwishRene NunezPhilmore Robertson Jr. Original Research Article Open access 28 November 2023 Pages: 21 - 33
Clinical and Laboratory Factors Related to Seizure and Serotonin Toxicity in Tramadol Intoxication: An Egyptian Study Ahmed Amin AliMahmoud Mohamed AbdeshafyFawzy Elbarbry Original Research Article 25 November 2023 Pages: 963 - 971
Safety Concerns with Nusinersen, Risdiplam, and Onasemnogene Abeparvovec in Spinal Muscular Atrophy: A Real-World Pharmacovigilance Study Wei ZhuangMei LuWanlong Lin Original Research Article 23 November 2023 Pages: 949 - 962
Correction: Pharmacokinetics and Safety of Erenumab after a Single Subcutaneous Injection Dose in Healthy Chinese Subjects Qi ShenYing JinZhenlei Wang Correction 22 November 2023 Pages: 973 - 974
Is Alpelisib Plus Fulvestrant Cost-Effective for Treating PIK3CA-Mutation, HR+/HER2− Advanced Breast Cancer in the USA? Wenhua WuHuiting LinXiaoxia Wei Original Research Article 17 November 2023 Pages: 939 - 948
Tauro-Urso-Deoxycholic Acid Trials in Amyotrophic Lateral Sclerosis: What is Achieved and What to Expect Maria Lo GiudiceAntoniangela CoccoAlberto Albanese Leading Article Open access 16 November 2023 Pages: 893 - 903
Glucagon-Like Peptide-1 Receptor Agonist and Risk of Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials Xiaojuan JiaoPing PengYunfeng Shen Systematic Review 08 November 2023 Pages: 915 - 926
Monotherapy Versus Combination Therapy in the Treatment of Painful Diabetic Neuropathy: A Systematic Review and Meta-analysis Julyana Medeiros DantasMariana de Jesus OliveiraDaniel Campinho Schachter Systematic Review 08 November 2023 Pages: 905 - 914
Efficacy and Safety of Switching from Sitagliptin to Ipragliflozin in Obese Japanese Patients with Type 2 Diabetes Mellitus: A Single-Arm Multicenter Interventional Study Kentaro WatanabeSusumu YamaguchiHisamitsu Ishihara Original Research Article 07 November 2023 Pages: 927 - 937
Pharmacokinetics and Safety of Eptinezumab in Healthy Chinese Participants: A Randomized Clinical Trial Xue-Ning LiHong-Rong XuFrank Larsen Original Research Article Open access 02 November 2023 Pages: 873 - 881
Use of Acitretin Among Girls and Women of Childbearing Age and Occurrence of Acitretin-Exposed Pregnancies in Germany Jonas ReinoldBianca KollhorstUlrike Haug Original Research Article Open access 31 October 2023 Pages: 865 - 872
